KYTX
KYTX
US5019761049
Kyverna Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
395.18M EUR
548.59M EUR
522.4M EUR
Enterprise Value
215.76M EUR
549.78M EUR
523.96M EUR
Valuation Multiples
Trailing P/E
--
--
--
Forward P/E
-2.02x
--
--
Price to Sales
--
--
--
Price to Book
2.38x
3.31x
2.67x
EV/Revenue
--
--
--
EV/EBITDA
-1.37x
--
--
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
-27.25%
-29.21%
-29.01%
ende